Global /United States /Healthcare /Medical Devices /ATEC
chevron_leftBack
Alphatec Holdings, Inc. logo

Alphatec Holdings, Inc.

ATEC
NASDAQ: ATEC Delayed
9.30USD -0.5%
As of 13 June 2026, Alphatec Holdings, Inc. has a market cap of $1.41B USD, ranking #8808 globally and #1936 in the United States. It ranks #740 in the Healthcare sector, and #145 in the Medical Devices industry.
Global Rank
8808
Country Rank
1936
Sector Rank
740
Industry Rank
145
Key Stats
Market Cap
$1.41BUSD
Enterprise Value
$1.83BUSD
Revenue (TTM)
$764.16MUSD
EBITDA (TTM)
$19.53MUSD
Net Income (TTM)
-$143.36MUSD
EBITDA Margin
2.6%
Profit Margin
-19%
PS Ratio
1.8
PB Ratio
113.1
EV/EBITDA
93.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Patrick Miles open_in_new
Employees
913
Founded
1990
IPO
02 Jun 2006
Website
atecspine.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.5% -12% -15% -39% -44% -16%

News

Loading...

ATEC Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
ATEC
Alphatec Holdings Inc
ISIN: US02081G2012
Shares Out.:
153.789M1 Shares Float: 120.993M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
9.30 USD
Frankfurt Stock Exchange
MIC: XFRA
L1Z1
Alphatec Holdings Inc
ISIN: US02081G2012
TV:
SA:
YF:
GF:
BA:
MS:
7.70 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
12K%
25.8
$160.73B
11K%
56.7
$159.07B
11K%
25.6
DHR
$126.55B
9K%
34.7
SYK
$120.69B
8K%
38.3
$84.93B
6K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
7K%
22.2
$97.46B
84.32B EUR
7K%
36.7
7741
$61.41B
9.83T JPY
4K%
40.0
$45.47B
39.34B EUR
3K%
18.7
ALC
$36.38B
28.99B CHF
2K%
37.9
$30.06B
203.66B CNY
2K%
26.0
chevron_leftBack